LeMaitre Vascular Inc
$ 91.62
0.22%
02 Jun - close price
- Market Cap 2,089,015,000 USD
- Current Price $ 91.62
- High / Low $ 92.06 / 90.28
- Stock P/E 33.61
- Book Value 17.80
- EPS 2.72
- Next Earning Report 2026-08-10
- Dividend Per Share $0.85
- Dividend Yield 0.9 %
- Next Dividend Date 2026-06-04
- ROA 0.07 %
- ROE 0.17 %
- 52 Week High 117.72
- 52 Week Low 78.29
About
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Analyst Target Price
$118.75
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-25 | 2025-11-06 | 2025-08-05 | 2025-05-01 | 2025-02-27 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-01 | 2023-08-01 |
| Reported EPS | 0.68 | 0.68 | 0.75 | 0.6 | 0.48 | 0.49 | 0.49 | 0.52 | 0.44 | 0.38 | 0.33 | 0.37 |
| Estimated EPS | 0.66 | 0.66 | 0.56 | 0.57 | 0.5 | 0.49 | 0.43 | 0.47 | 0.39 | 0.36 | 0.3 | 0.32 |
| Surprise | 0.02 | 0.02 | 0.19 | 0.03 | -0.02 | 0 | 0.06 | 0.05 | 0.05 | 0.02 | 0.03 | 0.05 |
| Surprise Percentage | 3.0303% | 3.0303% | 33.9286% | 5.2632% | -4% | 0% | 13.9535% | 10.6383% | 12.8205% | 5.5556% | 10% | 15.625% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.81 |
| Currency | USD |
Previous Dividend Records
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | May 2025 | Jan 1970 | Mar 2025 | Dec 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-06-04 | 2026-03-26 | 2025-12-04 | 2025-09-04 | 2025-05-29 | None | 2025-03-27 | 2024-12-05 | 2024-08-29 | 2024-05-30 |
| Amount | $0.25 | $0.25 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.16 | $0.16 | $0.16 |
Next Dividend Records
| Dividend per share (year): | $0.85 |
| Dividend Yield | 0.9% |
| Next Dividend Date | 2026-06-04 |
| Ex-Dividend Date | 2026-05-21 |
Recent News: LMAT
2026-05-28 12:39:03
This Simply Wall St analysis of LeMaitre Vascular (Nasdaq: LMAT) details the company's stock performance, financial health, growth prospects, and recent news. It highlights the company's strong past performance and dividends, despite some analyst concerns regarding insider selling and board refreshment, noting an updated analyst price target of US$118.75 and recent Q1 2026 revenue growth.
2026-05-27 07:10:00
AlphaQuest LLC significantly increased its stake in LeMaitre Vascular (NASDAQ:LMAT) by 155.4% in the fourth quarter, now owning 27,521 shares valued at $2.23 million. This comes despite recent insider selling, with insiders offloading 269,891 shares worth $28.97 million over the past 90 days. The company reported strong financial results, beating EPS estimates and raising guidance, and announced a quarterly dividend of $0.25 per share.
2026-05-21 08:27:36
Thrivent Financial for Lutherans significantly increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 492.0% in the fourth quarter, now owning 88,950 shares valued at $7.21 million. The article also details other institutional investor activity, LeMaitre Vascular's financial performance, recent insider selling, and current analyst ratings, with the stock holding a "Moderate Buy" consensus.
2026-05-20 20:40:36
LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced its participation in two investor conferences in June 2026. Management will be engaging in a fireside chat at the Jefferies Global Healthcare Conference on June 3rd and presenting at the Goldman Sachs Annual Global Healthcare Conference on June 10th. LeMaitre is a provider of devices and services for peripheral vascular disease.
2026-05-20 20:40:36
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in June 2026: the Jefferies Global Healthcare Conference and the Goldman Sachs Annual Global Healthcare Conference. Management will engage in a fireside chat at the Jefferies conference and provide a presentation at the Goldman Sachs event. The company specializes in devices and services for peripheral vascular disease.
2026-05-20 20:31:24
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in June. Management will attend the Jefferies Global Healthcare Conference on June 3, 2026, and the Goldman Sachs Annual Global Healthcare Conference on June 10, 2026. The company specializes in devices for peripheral vascular disease.
